In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
EMA recommends withdrawal of pholcodine medicines from EU market

EMA recommends withdrawal of pholcodine medicines from EU market

by In2Pharma | Dec 15, 2022 | News

Europe EMA’s safety committee, PRAC, has concluded its review of medicines containing pholcodine, which are used in adults and children to treat non-productive (dry) cough and, in combination with other active substances, for the treatment of symptoms of...

Recent Posts

  • Price display of OTC medicines
  • New fees for food supplement notifications
  • Revision IML Code of Ethics
  • New guideline on the use of D-mannose in food supplements
  • Adjusted fees for applications to EMA

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België